KIVRAK SALİM, D. Et Al. 2014. Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors. asian pac J cancer pre , vol.18, no.15 , 7737-40.

KIVRAK SALİM, D., MUTLU, H., KARAKURT ERYILMAZ, M., YALÇIN MÜSRİ, F., TURAL, D., GÜNDÜZ, Ş., ... COŞKUN, H. Ş.(2014). Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors. asian pac J cancer pre , vol.18, no.15, 7737-40.

KIVRAK SALİM, DERYA Et Al. "Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors," asian pac J cancer pre , vol.18, no.15, 7737-40, 2014

KIVRAK SALİM, DERYA K. Et Al. "Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors." asian pac J cancer pre , vol.18, no.15, pp.7737-40, 2014

KIVRAK SALİM, D. Et Al. (2014) . "Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors." asian pac J cancer pre , vol.18, no.15, pp.7737-40.

@article{article, author={DERYA KIVRAK SALİM Et Al. }, title={Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors}, journal={asian pac J cancer pre}, year=2014, pages={7737-40} }